Fulgent Genetics, Inc.FLGTNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P36
Within normal range
vs 5Y Ago
-0.2x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | -13.74% | +20.5% |
| 2024 | -17.28% | +66.1% |
| 2023 | -50.98% | -245.0% |
| 2022 | 35.17% | -49.2% |
| 2021 | 69.21% | -0.4% |
| 2020 | 69.51% | +1246.6% |
| 2019 | 5.16% | +137.9% |
| 2018 | -13.61% | -45.3% |
| 2017 | -9.36% | -182.0% |
| 2016 | 11.42% | - |